Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Efficacy of Chemoradiotherapy and Immunotherapy”

18 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 18 results

Not applicableLooking for participantsNCT06197776
What this trial is testing

Investigation of Multi-omics Technique to Predict the Efficacy of Chemoradiotherapy Combined With Immunotherapy for r/m NPC

Who this might be right for
Multi-omics TechniqueNasopharyngeal CarcinomaRecurrent and Metastatic Nasopharyngeal Carcinoma+1 more
Sun Yat-sen University 50
Testing effectiveness (Phase 2)Looking for participantsNCT07347951
What this trial is testing

A Single-center, Phase II Study on Efficacy & Safety of SCRT+CAPOX+Serplulimab+Bevacizumab for MSS Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer (LARC)
First Affiliated Hospital of Wenzhou Medical University 30
Not applicableLooking for participantsNCT06792786
What this trial is testing

Dynamic Changes of CtDNA to Evaluate the Efficacy of Immunoconsolidation Therapy After Radiotherapy and Chemotherapy for Esophageal Cancer

Who this might be right for
Esophageal CancerCtDNA
The Central Hospital of Lishui City 51
Testing effectiveness (Phase 2)Looking for participantsNCT06843889
What this trial is testing

A Phase II Study of Toripalimab Combined With Sequential Neoadjuvant Chemoradiotherapy in Patients With Esophageal Squamous Cell Carcinoma

Who this might be right for
Locally Advanced Esophageal Squamous Cell Carcinoma
Nanfang Hospital, Southern Medical University 34
Testing effectiveness (Phase 2)Looking for participantsNCT06421376
What this trial is testing

Induction Chemoimmunotherapy Combined With Chemoradiotherapy in Esophageal Cancer

Who this might be right for
Esophageal CancerImmunotherapyInduction Therapy+2 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 60
Testing effectiveness (Phase 2)Looking for participantsNCT05758116
What this trial is testing

Tislelizumab Consolidation Therapy After Radiotherapy or Sequential Chemoradiation in Locally Advanced NSCLC Patients

Who this might be right for
Non-small Cell Lung CancerConsolidation ImmunotherapyRadiotherapy or Sequential Chemoradiation
Peking University Cancer Hospital & Institute 20
Testing effectiveness (Phase 2)Looking for participantsNCT05311566
What this trial is testing

PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer

Who this might be right for
Cervical CarcinomaChemoradiotherapyAnti-programmed Cell Death Receptor 1+6 more
Lei Li 92
Testing effectiveness (Phase 2)Looking for participantsNCT06187597
What this trial is testing

Consolidation of Toripalimab After Chemoradiotherapy in Elderly Esophageal Cancer (EC-CRT-007)

Who this might be right for
Locally Advanced Esophageal Squamous Cell Carcinoma
Sun Yat-sen University 140
Not applicableLooking for participantsNCT06009705
What this trial is testing

Toripalimab Combined With Radiotherapy and S-1 for Older Patients With Esophageal Cancer

Who this might be right for
Esophageal Carcinoma
Hebei Medical University Fourth Hospital 56
Testing effectiveness (Phase 2)UnknownNCT05596890
What this trial is testing

Patient-reported Outcomes in Preoperative Immunochemotherapy/Radiotherapy-treated Esophageal Cancer Patients

Who this might be right for
Esophageal Squamous Cell CarcinomaPatient-reported OutcomesImmunotherapy
Guangdong Provincial People's Hospital 50
Testing effectiveness (Phase 2)WithdrawnNCT05481775
What this trial is testing

Evaluating Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy Followed by Consolidation Immunotherapy for Locally Advanced Non-small Cell Lung Cancer

Who this might be right for
Locally Advanced Non-small Cell Lung CancerEfficacy and Safety
Sun Yat-sen University
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05505461
What this trial is testing

Neoadjuvant Immunotherapy and Chemoradiotherapy for Locally Advanced Esophagogastric Junction Adenocarcinoma

Who this might be right for
Adenocarcinoma of Esophagogastric Junction
Peking University People's Hospital 26
Not applicableLooking for participantsNCT07080437
What this trial is testing

An Observational Study on the Safety and Efficacy of Immunotherapy Combined With Concurrent Chemoradiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Three Gorges Hospital of Chongqing University 40
Testing effectiveness (Phase 2)Study completedNCT01280552
What this trial is testing

ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)

Who this might be right for
Glioblastoma Multiforme
Precision Life Sciences Group 124
Not applicableNot Yet RecruitingNCT07185893
What this trial is testing

A Multicenter, Open-label, Randomized Controlled Trial Evaluating the Efficacy and Safety of Romiplostim N01 in the Treatment of Thrombocytopenia Associated With Concurrent/Sequential Chemoradiotherapy and Chemotherapy Combined With/Without Immunotherapy in Solid Tumors

Who this might be right for
Solid Tumor Malignancies, CancerCTIT-Chemotherapy Induced ThrombocytopeniaThrombocytopenia
Jun wang 106
Not applicableUnknownNCT04984148
What this trial is testing

Construction of CT Radiomics Model for Predicting the Efficacy of Immunotherapy in Patients With Stage III NSCLC

Who this might be right for
Stage III Non-small Cell Lung Cancer
Guangdong Provincial People's Hospital 70
Testing effectiveness (Phase 2)Looking for participantsNCT06173986
What this trial is testing

Immunotherapy in Combination With Chemoradiotherapy in Unresectable Locally Advanced Esophageal Cancer

Who this might be right for
Esophageal Squamous Cell CarcinomaUnresectable Locally Advanced Esophageal Cancer
Shanghai Chest Hospital 50
Testing effectiveness (Phase 2)UnknownNCT05634564
What this trial is testing

Concurrent Chemoradiotherapy Combined With Immunotherapy in Patients With Potentially Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Carcinoma
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 62